Search results
Strong trial results for Pfizer lung cancer drug
The Raw Story· 4 hours agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 24 hours agoA month has gone by since the last earnings report for Pfizer (PFE). Shares have added about 1.8% in...
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
Motley Fool via Yahoo Finance· 1 day agoFool.com contributor Parkev Tatevosian reviews Pfizer (NYSE: PFE) stock for passive income...
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 1 day agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 1 day agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 24 hours agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year —...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 3 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca...
How To Earn $500 A Month From Pfizer Stock
Benzinga· 1 day agoShares of Pfizer Inc. PFE closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Pfizer didn’t sue Barbara O’Neill over bird flu secrets
Politifact· 18 hours agoAn Instagram post from the same day claimed the recent legal troubles of hip-hop mogul Sean "Diddy"...
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 21 hours agoOn Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial...
